Verorab

Verorab is an inactivated rabies virus vaccine used for rabies prevention after exposure or pre-exposure. This EU-manufactured vaccine provides active immunization against rabies virus. Ideal for travel or occupational risk, it is administered intradermally or intramuscularly. Protect yourself with verified rabies prophylaxis.

Verorab is used for pre-exposure and post-exposure prophylaxis against rabies virus infection. It is indicated for individuals at continuous or frequent risk of exposure, such as travelers to endemic regions or those in high-risk occupations. The vaccine helps the body develop immunity to the rabies virus, reducing the risk of infection after potential exposure. It is not a treatment for active rabies infection.

Verorab stimulates the immune system to produce antibodies against the rabies virus. Common effects include mild pain, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue. These effects are generally temporary and indicate the body’s immune response.

Store Verorab refrigerated between 2°C and 8°C, and protect from light. Do not freeze. Before administration, check the vaccine for particulate matter or discoloration. Inform your healthcare provider of any allergies or previous reactions to vaccines. Ensure the vaccine is administered by a trained professional using sterile techniques.

Verorab may interact with immunosuppressive therapies, reducing its effectiveness. Avoid receiving other vaccines simultaneously unless advised by a healthcare provider. Inform your provider of any recent blood transfusions or immunoglobulin treatments. Alcohol and certain medications may affect immune response; consult a healthcare professional for guidance.